Demystifying a key receptor in substance use and neuropsychiatric disorders
Researchers at the Icahn School of Medicine at Mount Sinai have uncovered insights into the potential mechanism of action of the antipsychotic medication asenapine, a possible therapeutic target for substance use and neuropsychiatric ...
Jan 2, 2024
0
48